Fangzhou Recognized for AI-Driven Chronic Disease Care by KPMG China Healthcare 50 List

Fangzhou Inc., a prominent provider of AI-driven Internet healthcare solutions, has secured a coveted spot on the KPMG China Healthcare 50 list for its innovative approach in chronic disease management. The company’s expertise in AI-driven solutions has been acknowledged for “extending chronic disease management into the home, with trusted long-term care”. With China’s population aged 60 and above surpassing 320 million by the end of 2025, there is a growing demand for diversified and high-quality care services, prompting the evolution of the health and wellness sector in the country. Fangzhou has strategically expanded its AI+H2H (Hospital-to-Home) smart healthcare ecosystem to…